| Development cohort | Test cohort | ||||
---|---|---|---|---|---|---|
Non-metastasis (n = 96) | Metastasis (n = 30) | P-value | Non-metastasis (n = 32) | Metastasis (n = 11) | P-value | |
Age (years) | 50.45 ± 10.59 | 52.57 ± 9.54 | 0.330 | 53.16 ± 9.73 | 50.64 ± 7.19 | 0.436 |
Tumor size | Â | Â | 0.008 | Â | Â | 0.035 |
 < 2 cm | 23 | 2 |  | 9 | 0 |  |
 2–4 cm | 44 | 10 |  | 17 | 5 |  |
 > 4 cm | 29 | 18 |  | 6 | 6 |  |
FIGO stage | Â | Â | 0.219 | Â | Â | 0.278 |
 IB | 68 | 17 |  | 27 | 7 |  |
 IIA | 24 | 10 |  | 4 | 3 |  |
 IIB | 4 | 3 |  | 1 | 1 |  |
ADC value (×10− 3mm2/s) | 0.96 ± 0.14 | 0.89 ± 0.12 | 0.023 | 0.98 ± 0.14 | 0.86 ± 0.11 | 0.015 |
SCCa level (ng/mL) | 4.51 ± 7.38 | 11.32 ± 13.80 | 0.001 | 3.93 ± 4.76 | 8.79 ± 6.46 | 0.007 |